Testosterone replacement therapy is covered by most major insurance plans, but only when it’s prescribed for a documented medical condition, not for age-related decline alone. The key distinction insurers make is between hypogonadism caused by a specific medical problem (which they’ll cover) and low testosterone tied to normal aging (which they typically won’t). Getting approved requires jumping through several hoops, starting with specific blood tests taken at specific times of day.
What Insurers Require for Approval
Every major insurer follows a similar playbook. Before coverage kicks in, you need a confirmed diagnosis of hypogonadism, meaning your body isn’t producing enough testosterone due to a problem with the testes, pituitary gland, or the part of the brain that controls hormone signaling. The underlying cause matters: conditions like Klinefelter’s syndrome, prior chemotherapy, pituitary tumors, testicular injury, or surgical removal of the testes all qualify. A vague complaint of fatigue and low libido, without an identifiable medical cause, generally does not.
The blood work requirements are strict. You’ll need at least two morning blood draws, typically between 8 a.m. and 10 a.m., on separate days at least a week apart. Testosterone levels naturally peak in the morning and drop throughout the day, so insurers won’t accept afternoon results. Both tests must show levels below the lab’s normal range. Oregon’s state formulary criteria, which mirror what many private insurers use, set the threshold at a total testosterone level below 300 ng/dL, or below 350 ng/dL if your free testosterone is also low (under 50 pg/mL). Your insurer may use slightly different numbers, but the general range is similar.
Aetna, Blue Cross Blue Shield, and others all require this two-test confirmation before they’ll authorize a prescription. Your doctor will also need to document your symptoms, physical exam findings, and the lab results in your medical record. Some plans require prior authorization, meaning your doctor submits paperwork to the insurer and waits for approval before writing the prescription.
What Insurance Won’t Cover
The biggest exclusion across nearly all plans is age-related low testosterone, sometimes called late-onset hypogonadism or “male menopause.” Testosterone levels naturally decline about 1% per year after age 30, and most insurers consider this a normal part of aging rather than a disease. If your levels are low but your doctor can’t point to a specific medical cause, expect a denial.
Medicare spells this out explicitly: coverage is not considered medically necessary for hypogonadism due to aging, idiopathic hypogonadism (meaning no known cause), or for patients interested in preserving fertility, since TRT suppresses sperm production. Performance enhancement and bodybuilding are also excluded across the board.
Several medical conditions will also disqualify you. These include:
- Active breast or prostate cancer (prostate cancer patients may qualify if they’ve been disease-free for at least two years after surgery)
- Recent cardiovascular events such as a heart attack, stroke, or cardiac procedure within the past six months
- Elevated hematocrit (red blood cell concentration above 48-50%), since testosterone can thicken blood further
- Elevated PSA levels above 4 ng/mL, or above 3 ng/mL for men at higher risk of prostate cancer
- Untreated obstructive sleep apnea
Your doctor is also required to document that they discussed the cardiovascular and blood clot risks with you before starting treatment. Insurers check for this documentation.
How Medicare Handles TRT
Medicare covers testosterone for symptomatic hypogonadism caused by a disorder of the testes, pituitary gland, or brain, as well as for delayed puberty and gender dysphoria. The same exclusions for age-related decline and recent cardiovascular events apply. Medicare Part D (the prescription drug benefit) covers the medications themselves, and the cost difference between formulations is dramatic. Based on Medicare claims data, the annual cost per beneficiary was about $156 for injectable testosterone and roughly $2,135 for topical gels or patches. Even with Part D coverage, your copay will reflect that gap.
Injections vs. Gels: What Plans Prefer
Most insurance formularies, including the VA system, place injectable testosterone (typically testosterone cypionate) on a preferred tier with lower copays. It’s the cheapest form by a wide margin. Topical gels and patches cost significantly more and often sit on higher formulary tiers, meaning larger copays or additional prior authorization steps. Some plans require you to try and fail on injections before they’ll approve a gel or patch.
If your doctor prescribes a brand-name gel when a generic injection is available, expect pushback from your insurer. This is one of the most common reasons for initial denials. Switching to the generic injectable formulation often resolves the issue.
Staying Covered After Approval
Initial authorizations typically last up to 12 months. During that first year, your insurer will expect follow-up blood work every three to six months to confirm the treatment is working and to monitor for side effects like elevated red blood cell counts. After the first year, annual lab work is the norm. When your authorization period expires, your doctor submits for reauthorization, and the insurer reviews your updated labs and symptom documentation.
If your testosterone levels normalize on treatment and you’re not experiencing complications, reauthorization is usually straightforward. But if your hematocrit creeps above 50% or your PSA rises significantly, your insurer may require a treatment pause or deny continued coverage until those issues are addressed.
The Cash-Pay Alternative
A growing number of online and specialty TRT clinics operate entirely outside of insurance. These cash-pay clinics charge a monthly fee, typically covering consultations, lab work, and medications in one package. The appeal is speed and simplicity: no prior authorization, no waiting for approval, and often more flexible prescribing criteria. Some men who don’t meet the strict diagnostic criteria for insurance coverage, particularly those with age-related decline, turn to these clinics as their only option.
The tradeoff is cost. You’re paying entirely out of pocket, and monthly fees can add up to well over $1,000 per year depending on the clinic and formulation. For comparison, generic injectable testosterone through insurance might cost you just a copay of $10 to $30 per month. If you do qualify for insurance coverage, it’s almost always the cheaper path, even with the extra paperwork and blood draws.
How to Improve Your Chances of Approval
The most common reasons for denial are incomplete documentation, afternoon blood draws, only one test instead of two, or a diagnosis code that doesn’t match a covered condition. To give yourself the best shot, schedule both blood draws early in the morning, make sure your doctor uses the correct diagnostic codes for your specific type of hypogonadism, and confirm that your plan requires prior authorization before filling the prescription. If you’re denied, ask your doctor’s office to submit an appeal with complete lab results and clinical notes. Many initial denials are overturned when the right documentation is provided.